Maine Biotechnology Services, Inc. (MBS) is a custom antibody discovery company located in Portland, Maine. MBS was founded in 1990 by Dr. Joseph Chandler as a full service antibody development and production company. Since then, MBS has stayed committed to building on the products and services offered, while at the same time improving and refining core proficiencies in monoclonal antibody development, polyclonal antibody development, bulk antibody production, purification, and antibody post processing. In 2001, MBS became a cGMP facility to solidify our commitment to quality and our place as a bulk supplier to IVD companies. In 2002, MBS became 1774 EU/2002 approved allowing us to continue sending our products into the European Union and in 2004, our ascites production facility was expanded to meet the increasing needs of our customer base. MBS continues to use over 20 years of experience and proprietary protocols to meet the ever changing needs of diagnostic and pharmaceutical companies. Most recently, we have partnered with pharmaceutical companies in their quest to meet regulatory assay requirements for monitoring novel therapeutics. Whatever the end use, MBS maintains customer service and communication as our paramount priorities.